PharmaBoardroom

New Drugs Approved in the USA 2018

59 novel drugs were approved in the USA in 2018, representing a leap from the 46 approved in 2017 and 22 approved in 2016. 19 of the 59 drugs (32…

Healthcare Politics in 2019

Aditya Bhattacharji manages Eurasia Group‘s healthcare analysis. In this article, he gives his predictions for the political landscape in…

Juan Luis Fernández Balaguer – General Manager,…

Juan Luis Fernández Balaguer, general manager of Laboratorios Combix, the Spanish affiliate of Zydus Cadila, shares the milestones achieved by the…

PJ Brooks – Program Officer, Division of Clinical Innovation…

PJ Brooks PhD, program director in the Office of Rare Diseases Research at the National Center for Advancing Translational Sciences (NCATS), National…

Alexander Eggermont – General Director, Gustave Roussy,…

Professor Alexander Eggermont, general director of Gustave Roussy, gives insights into the transformation of the Hospital under his ten-year…

The Long and Short of Drug Shortages in America

Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) weighs in on the issue of drug shortages in…

Representative Organisations and Forums of the Pharmaceutical…

LEEM - Les Entreprises du Médicament (Drug Companies) Key people: [caption id="attachment_83137" align="alignleft"…

Roger Zbinden – Head, Swiss Business Hub, South Korea

Roger Zbinden, head of the Swiss Business Hub Korea, explains their efforts to raise the profile of the South Korean market for Swiss business. Dr…

2018 Venture Investment Activity in Life Sciences

David H. Crean, PhD, Managing Director for Objective Capital Partners, a leading investment banking advisory firm examines the venture investment…

The NFL’s Opioid Crisis: Is Cannabis the Answer?

With an increasing number of NFL players relying on potentially dangerous prescription painkillers, does the league need to relax its attitude to…

Christophe Cizeron – President, Lyonbiopole, France

Christophe Cizeron, president of Lyonbiopole, discusses the important economic and industrial position of the research cluster in the Rhone-Alps…

How the USA’s CREATES Act Restores Competition to the…

Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) discusses the Creating and Restoring Equal…

Tagged with US